首頁 > 市場調查報告書 > 醫療設備

體外診斷 POC診斷

市場調查報告書

商品編碼

1922397

日本照護現場診斷市場依產品類型、平台、處方模式、最終用戶和地區分類，2026-2034年

Japan Point of Care Diagnostics Market Report by Product Type, Platform, Prescription Mode, End User, and Region 2026-2034

出版日期: 2026年01月01日 | 出版商:

IMARC | 英文 121 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2025年，日本照護現場診斷市場規模達19億美元。 IMARC Group預測，到2034年，該市場規模將達到40億美元，2026年至2034年的複合年成長率（CAGR）為8.74%。癌症、糖尿病和心血管疾病等慢性病的增加，人們對社區診所、藥局和家庭環境的偏好轉變，以及人口老化加劇，是推動市場成長的主要因素。

照護現場（POCD）是指在患者照護地點或附近進行的醫學檢測，能夠快速提供結果，以便即時做出臨床決策。這些檢測操作簡便，醫護人員只需接受極少的訓練即可上手。它們涵蓋範圍廣泛，包括感染疾病的檢測。即時診斷提高了醫療檢測的可近性，尤其是在資源匱乏的地區。它們還有助於預防傳染病在社區和醫療機構中的傳播。即時診斷減少了患者多次就診的次數，既方便又降低了醫療成本。它們有助於根據即時數據管理和調整治療方案。即時診斷廣泛應用於急診護理，用於快速評估和診斷心臟病發作、敗血症和呼吸窘迫等嚴重。

日本照護現場診斷（POCD）市場趨勢：

癌症、糖尿病和心血管疾病等慢性病的日益增多，以及對定期監測和即時醫療回應需求的不斷成長，是推動日本即時檢測設備（POCD）需求的關鍵因素。此外，人口老化和住院率上升也促進了市場成長。快速的都市化、個人生活方式的改變以及肥胖和高血壓等文明病風險的增加，也推動了國內市場的發展。即時檢測設備能夠對這些疾病進行及時監測和管理，從而增加了對即時檢測設備的需求。人們越來越偏好選擇社區診所、藥局和家庭就醫，這也對市場產生了正面影響。此外，日本政府持續致力於醫療保健產業的現代化，為市場帶來了良好的前景。政府已實施多項措施，並提供優惠的報銷政策，以促進醫療服務中的技術整合。此外，日本強大的科技產業正積極推動小型化和自動化，確保即時檢測設備達到最高的可靠性和易用性標準。同時，日本醫療服務提供者、診斷公司和研究機構之間日益緊密的合作也推動了市場前景的積極發展。這些夥伴關係促進了創新，並推動了針對特定疾病的即時檢測（POC）解決方案的開發。此外，預防醫學和疾病早期檢測的日益普及也促進了市場成長。即時檢測使個人能夠定期監測自身健康狀況，從而倡導積極主動的醫療保健方式，並減輕醫療機構的負擔。日本民眾對定期體檢重要性的認知不斷提高，也對市場產生了正面影響。

本報告解答的關鍵問題：

日本照護現場診斷市場目前的表現如何？未來幾年又將如何發展？
新冠疫情對日本照護現場診斷市場產生了哪些影響？
日本照護現場診斷市場依產品類型分類的組成是怎樣的？
日本照護現場診斷市場依平台分類的細分如何？
日本照護現場診斷市場依處方模式分類的組成是怎樣的？
日本照護現場診斷市場依最終用戶分類的組成是怎樣的？
請介紹日本照護現場診斷市場價值鏈的各個環節。
日本照護現場診斷的關鍵促進因素和挑戰是什麼？
日本照護現場診斷市場的結構是怎麼樣的？主要企業有哪些？
日本照護現場診斷市場的競爭程度如何？

Japan point of care diagnostics market size reached USD 1.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 4.0 Billion by 2034, exhibiting a growth rate (CAGR) of 8.74% during 2026-2034. The increasing prevalence of chronic diseases like cancer, diabetes, and cardiovascular problems, shifting preferences towards community clinics, pharmacies, and home settings, and the expanding aging population represent some of the key factors driving the market.

Point of care diagnostics (POCD) refers to medical tests conducted at or near the site of patient care, providing rapid results for immediate clinical decisions. It is user-friendly, requiring minimal training for healthcare professionals and encompasses a broad spectrum of tests for infectious diseases, chronic conditions, pregnancy, and various biomarkers. It enhances accessibility to medical testing, especially in resource-limited settings. It aids in preventing the spread of contagious diseases within communities or healthcare facilities. It reduces the need for multiple clinical visits, offering convenience and potentially lowering healthcare costs. It assists in managing and adjusting treatment plans based on real-time data. It is widely used in emergency medicine to quickly assess and diagnose critical conditions, such as cardiac events, sepsis, or respiratory distress.

Japan Point of Care Diagnostics Market Trends:

The increasing prevalence of chronic diseases like cancer, diabetes, and cardiovascular problems, coupled with this rising need for regular monitoring and immediate medical attention, represents one of the primary factors driving the demand for POCD in Japan. Additionally, the expanding aging population and the increasing hospitalization rates are facilitating the market growth. Along with this, rapid urbanization, changing lifestyles of individuals, and the rising risk of lifestyle-related diseases, such as obesity and hypertension, are driving the market in the country. POCD facilitates the timely monitoring and management of these conditions, leading to greater demand for POC testing devices. Apart from this, shifting preferences towards community clinics, pharmacies, and home settings are influencing the market positively. Moreover, governing authorities of the country are continuously focusing on the modernization of the healthcare sector, which is offering a favorable market outlook. They are implementing several initiatives and offering favorable reimbursement rates that encourage technological integration in healthcare services. Furthermore, the robust technology sector of Japan is actively engaged in miniaturization and automation, ensuring that POCDs meet the highest standards of reliability and usability. Along with this, rising collaborations between healthcare providers, diagnostic companies, and research institutions in Japan are creating a positive outlook for the market. These partnerships foster innovation and enable the development of tailored POC solutions for specific medical conditions. In addition, the rising shift towards preventive healthcare and early disease detection is bolstering the market growth. POC diagnostics empower individuals to monitor their health regularly, fostering a proactive approach to healthcare and reducing the burden on healthcare facilities. The growing awareness among the Japanese population about the importance of regular health check-ups is influencing the market positively.

Japan Point of Care Diagnostics Market Segmentation:

Product Type Insights:

Blood-Glucose Monitoring Kit
Cardio-Metabolic Monitoring Kit
Pregnancy and Fertility Testing Kit
Infectious Disease Testing Kit
Cholesterol Test Strip
Hematology Testing Kit
Others

Platform Insights:

Lateral Flow Assays
Dipsticks
Microfluidics
Molecular Diagnostics
Immunoassays

Prescription Mode Insights:

Prescription-Based Testing
OTC Testing

End User Insights:

Professional Diagnostic Centers
Home Care
Research Laboratories
Others

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan point of care diagnostics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan point of care diagnostics market?
What is the breakup of the Japan point of care diagnostics market on the basis of product type?
What is the breakup of the Japan point of care diagnostics market on the basis of platform?
What is the breakup of the Japan point of care diagnostics market on the basis of prescription mode?
What is the breakup of the Japan point of care diagnostics market on the basis of end user?
What are the various stages in the value chain of the Japan point of care diagnostics market?
What are the key driving factors and challenges in the Japan point of care diagnostics?
What is the structure of the Japan point of care diagnostics market and who are the key players?
What is the degree of competition in the Japan point of care diagnostics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Point of Care Diagnostics Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Point of Care Diagnostics Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Point of Care Diagnostics Market - Breakup by Product Type

6.1 Blood-Glucose Monitoring Kit
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 Cardio-Metabolic Monitoring Kit
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)
6.3 Pregnancy and Fertility Testing Kit
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2020-2025)
- 6.3.3 Market Forecast (2026-2034)
6.4 Infectious Disease Testing Kit
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2020-2025)
- 6.4.3 Market Forecast (2026-2034)
6.5 Cholesterol Test Strip
- 6.5.1 Overview
- 6.5.2 Historical and Current Market Trends (2020-2025)
- 6.5.3 Market Forecast (2026-2034)
6.6 Hematology Testing Kit
- 6.6.1 Overview
- 6.6.2 Historical and Current Market Trends (2020-2025)
- 6.6.3 Market Forecast (2026-2034)
6.7 Others
- 6.7.1 Historical and Current Market Trends (2020-2025)
- 6.7.2 Market Forecast (2026-2034)

7 Japan Point of Care Diagnostics Market - Breakup by Platform

7.1 Lateral Flow Assays
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Dipsticks
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)
7.3 Microfluidics
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2020-2025)
- 7.3.3 Market Forecast (2026-2034)
7.4 Molecular Diagnostics
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2020-2025)
- 7.4.3 Market Forecast (2026-2034)
7.5 Immunoassays
- 7.5.1 Overview
- 7.5.2 Historical and Current Market Trends (2020-2025)
- 7.5.3 Market Forecast (2026-2034)

8 Japan Point of Care Diagnostics Market - Breakup by Prescription Mode

8.1 Prescription-Based Testing
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Forecast (2026-2034)
8.2 OTC Testing
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Forecast (2026-2034)

9 Japan Point of Care Diagnostics Market - Breakup by End User

9.1 Professional Diagnostic Centers
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Forecast (2026-2034)
9.2 Home Care
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2020-2025)
- 9.2.3 Market Forecast (2026-2034)
9.3 Research Laboratories
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2020-2025)
- 9.3.3 Market Forecast (2026-2034)
9.4 Others
- 9.4.1 Historical and Current Market Trends (2020-2025)
- 9.4.2 Market Forecast (2026-2034)

10 Japan Point of Care Diagnostics Market - Breakup by Region

10.1 Kanto Region
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2020-2025)
- 10.1.3 Market Breakup by Product Type
- 10.1.4 Market Breakup by Platform
- 10.1.5 Market Breakup by Prescription Mode
- 10.1.6 Market Breakup by End User
- 10.1.7 Key Players
- 10.1.8 Market Forecast (2026-2034)
10.2 Kansai/Kinki Region
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2020-2025)
- 10.2.3 Market Breakup by Product Type
- 10.2.4 Market Breakup by Platform
- 10.2.5 Market Breakup by Prescription Mode
- 10.2.6 Market Breakup by End User
- 10.2.7 Key Players
- 10.2.8 Market Forecast (2026-2034)
10.3 Central/ Chubu Region
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2020-2025)
- 10.3.3 Market Breakup by Product Type
- 10.3.4 Market Breakup by Platform
- 10.3.5 Market Breakup by Prescription Mode
- 10.3.6 Market Breakup by End User
- 10.3.7 Key Players
- 10.3.8 Market Forecast (2026-2034)
10.4 Kyushu-Okinawa Region
- 10.4.1 Overview
- 10.4.2 Historical and Current Market Trends (2020-2025)
- 10.4.3 Market Breakup by Product Type
- 10.4.4 Market Breakup by Platform
- 10.4.5 Market Breakup by Prescription Mode
- 10.4.6 Market Breakup by End User
- 10.4.7 Key Players
- 10.4.8 Market Forecast (2026-2034)
10.5 Tohoku Region
- 10.5.1 Overview
- 10.5.2 Historical and Current Market Trends (2020-2025)
- 10.5.3 Market Breakup by Product Type
- 10.5.4 Market Breakup by Platform
- 10.5.5 Market Breakup by Prescription Mode
- 10.5.6 Market Breakup by End User
- 10.5.7 Key Players
- 10.5.8 Market Forecast (2026-2034)
10.6 Chugoku Region
- 10.6.1 Overview
- 10.6.2 Historical and Current Market Trends (2020-2025)
- 10.6.3 Market Breakup by Product Type
- 10.6.4 Market Breakup by Platform
- 10.6.5 Market Breakup by Prescription Mode
- 10.6.6 Market Breakup by End User
- 10.6.7 Key Players
- 10.6.8 Market Forecast (2026-2034)
10.7 Hokkaido Region
- 10.7.1 Overview
- 10.7.2 Historical and Current Market Trends (2020-2025)
- 10.7.3 Market Breakup by Product Type
- 10.7.4 Market Breakup by Platform
- 10.7.5 Market Breakup by Prescription Mode
- 10.7.6 Market Breakup by End User
- 10.7.7 Key Players
- 10.7.8 Market Forecast (2026-2034)
10.8 Shikoku Region
- 10.8.1 Overview
- 10.8.2 Historical and Current Market Trends (2020-2025)
- 10.8.3 Market Breakup by Product Type
- 10.8.4 Market Breakup by Platform
- 10.8.5 Market Breakup by Prescription Mode
- 10.8.6 Market Breakup by End User
- 10.8.7 Key Players
- 10.8.8 Market Forecast (2026-2034)

11 Japan Point of Care Diagnostics Market - Competitive Landscape

11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant

12 Profiles of Key Players

12.1 Company A
- 12.1.1 Business Overview
- 12.1.2 Services Offered
- 12.1.3 Business Strategies
- 12.1.4 SWOT Analysis
- 12.1.5 Major News and Events
12.2 Company B
- 12.2.1 Business Overview
- 12.2.2 Services Offered
- 12.2.3 Business Strategies
- 12.2.4 SWOT Analysis
- 12.2.5 Major News and Events
12.3 Company C
- 12.3.1 Business Overview
- 12.3.2 Services Offered
- 12.3.3 Business Strategies
- 12.3.4 SWOT Analysis
- 12.3.5 Major News and Events
12.4 Company D
- 12.4.1 Business Overview
- 12.4.2 Services Offered
- 12.4.3 Business Strategies
- 12.4.4 SWOT Analysis
- 12.4.5 Major News and Events
12.5 Company E
- 12.5.1 Business Overview
- 12.5.2 Services Offered
- 12.5.3 Business Strategies
- 12.5.4 SWOT Analysis
- 12.5.5 Major News and Events

13 Japan Point of Care Diagnostics Market - Industry Analysis

13.1 Drivers, Restraints, and Opportunities
- 13.1.1 Overview
- 13.1.2 Drivers
- 13.1.3 Restraints
- 13.1.4 Opportunities
13.2 Porters Five Forces Analysis
- 13.2.1 Overview
- 13.2.2 Bargaining Power of Buyers
- 13.2.3 Bargaining Power of Suppliers
- 13.2.4 Degree of Competition
- 13.2.5 Threat of New Entrants
- 13.2.6 Threat of Substitutes
13.3 Value Chain Analysis